You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 8, August 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Residual Subthreshold Depressive Symptoms in Early Episode Relapse in Unipolar Major Depressive Disorder

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

There is increasing realization that unipolar major depressive disorder (MDD) is primarily a chronic disease with frequent episode relapses and recurrences across the life cycle and not merely an isolated single acute episode illness. This recent paradigm shift in the concept of unipolar MDD1 has made delay or prevention of episode relapse a fundamental treatment goal in the clinical management of unipolar MDD. It is surprising, that apart from the earlier series of investigations by the Pittsburgh group,2-3 that there is a scarcity of controlled studies, in which delay or prevention of episode relapse is the main focus of the study. Thus, we read with interest the study of Fava et al.4 This is an important study for which we wish to commend the authors. However, we would like to raise an issue that may be important for the interpretation of their data.

Our group has been investigating the clinical . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Residual Symptom Recovery From Major Affective Episodes in Bipolar Disorders and Rapid Episode Relapse/Recurrence
Judd et al.
Arch Gen Psychiatry 2008;65:386-394.
ABSTRACT | FULL TEXT  

Risperidone for Treatment-Refractory Major Depressive Disorder: A Randomized Trial
Mahmoud et al.
ANN INTERN MED 2007;147:593-602.
ABSTRACT | FULL TEXT  

Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Blumenthal et al.
Psychosom. Med. 2007;69:587-596.
ABSTRACT | FULL TEXT  

TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design
Trivedi et al.
Clin Trials 2006;3:291-305.
ABSTRACT  

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush et al.
NEJM 2006;354:1231-1242.
ABSTRACT | FULL TEXT  

Preventing Recurrent Depression Using Cognitive Therapy With and Without a Continuation Phase: A Randomized Clinical Trial
Jarrett et al.
Arch Gen Psychiatry 2001;58:381-388.
ABSTRACT | FULL TEXT  

Does Incomplete Recovery From First Lifetime Major Depressive Episode Herald a Chronic Course of Illness?
Judd et al.
Am. J. Psychiatry 2000;157:1501-1504.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.